Filing Details

Accession Number:
0001209191-15-028200
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-20 16:18:47
Reporting Period:
2015-03-18
Filing Date:
2015-03-20
Accepted Time:
2015-03-20 16:18:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Policy, Access & Value No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-18 5,375 $39.05 95,359 No 4 M Direct
Common Stock Acquisiton 2015-03-18 6,625 $45.11 101,984 No 4 M Direct
Common Stock Disposition 2015-03-18 12,000 $130.00 89,984 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-03-18 5,375 $0.00 5,375 $39.05
Common Stock Stock Option (right to buy) Disposition 2015-03-18 6,625 $0.00 6,625 $45.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-02-03 No 4 M Direct
39,125 2023-02-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  2. Fully vested.
  3. The option vests in 16 quarterly installments from 02/05/2013.